Some of these (FYN, DYRK1A, NOD2, CTSB, SV2C, and ITPKB) may serve as potential PD drug targets due to their involvement in pathways linked to neuroinflammation, autophagy, and neuronal degeneration. The gene discussed is CTSB; the disease is Parkinson disease.